Potential New Target for Dry Eye Disease—Oxidative Stress
Jinghua Bu,Yanbo Liu,Rongrong Zhang,Sijie Lin,Jingbin Zhuang,Le Sun,Lingyu Zhang,Hui He,Rongrong Zong,Yang Wu,Wei Li
DOI: https://doi.org/10.3390/antiox13040422
IF: 7.675
2024-03-30
Antioxidants
Abstract:Dry eye disease (DED) is a multifactorial condition affecting the ocular surface. It is characterized by loss of tear film homeostasis and accompanied by ocular symptoms that may potentially result in damage to the ocular surface and even vision loss. Unmodifiable risk factors for DED mainly include aging, hormonal changes, and lifestyle issues such as reduced sleep duration, increased screen exposure, smoking, and ethanol consumption. As its prevalence continues to rise, DED has garnered considerable attention, prompting the exploration of potential new therapeutic targets. Recent studies have found that when the production of ROS exceeds the capacity of the antioxidant defense system on the ocular surface, oxidative stress ensues, leading to cellular apoptosis and further oxidative damage. These events can exacerbate inflammation and cellular stress responses, further increasing ROS levels and promoting a vicious cycle of oxidative stress in DED. Therefore, given the central role of reactive oxygen species in the vicious cycle of inflammation in DED, strategies involving antioxidants have emerged as a novel approach for its treatment. This review aims to enhance our understanding of the intricate relationship between oxidative stress and DED, thereby providing directions to explore innovative therapeutic approaches for this complex ocular disorder.
biochemistry & molecular biology,chemistry, medicinal,food science & technology